JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...
Phase II study of neoadjuvant FLOT and chemoradiation for trimodality therapy of esophageal/GEJ adenocarcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
Gene expression analysis helps uncover how cells function, adapt, and contribute to disease. Techniques from microarray preprocessing to advanced single-cell proteomics offer complementary insights ...
Pregnancy care is now being transformed from its traditional, observational monitoring approach into a proactive, precision-led process, thanks to antenatal genomics.
The global DNA Polymerase Market is projected to expand from USD 397.7 million in 2025 to USD 725.8 million by 2035, growing ...